A detailed history of Elmwood Wealth Management, Inc. transactions in Pfizer Inc stock. As of the latest transaction made, Elmwood Wealth Management, Inc. holds 11,613 shares of PFE stock, worth $323,189. This represents 0.15% of its overall portfolio holdings.

Number of Shares
11,613
Previous 10,609 9.46%
Holding current value
$323,189
Previous $305,000 5.57%
% of portfolio
0.15%
Previous 0.22%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

BUY
$25.89 - $29.73 $25,993 - $29,848
1,004 Added 9.46%
11,613 $322,000
Q4 2023

Jan 30, 2024

SELL
$26.13 - $33.94 $239,455 - $311,026
-9,164 Reduced 46.35%
10,609 $305,000
Q3 2023

Nov 15, 2023

SELL
$32.09 - $37.51 $320 - $375
-10 Reduced 0.05%
19,773 $655,000
Q2 2023

Aug 10, 2023

SELL
$36.12 - $41.79 $3,070 - $3,552
-85 Reduced 0.43%
19,783 $725,000
Q1 2023

Apr 28, 2023

BUY
$39.39 - $51.28 $1,181 - $1,538
30 Added 0.15%
19,868 $810,000
Q4 2022

Jan 25, 2023

BUY
$41.75 - $54.5 $7,974 - $10,409
191 Added 0.97%
19,838 $0
Q3 2022

Nov 14, 2022

BUY
$43.76 - $53.42 $17,504 - $21,368
400 Added 2.08%
19,647 $860,000
Q4 2021

Feb 08, 2022

BUY
$41.32 - $61.25 $15,495 - $22,968
375 Added 1.99%
19,247 $1.14 Million
Q1 2021

May 13, 2021

BUY
$33.49 - $37.77 $3,349 - $3,777
100 Added 0.53%
18,872 $683,000
Q2 2020

Aug 13, 2020

BUY
$30.12 - $36.54 $32,650 - $39,609
1,084 Added 6.13%
18,772 $614,000
Q1 2020

May 12, 2020

SELL
$27.03 - $38.62 $23,029 - $32,904
-852 Reduced 4.6%
17,688 $547,000
Q4 2018

Feb 14, 2019

BUY
$38.47 - $43.86 $38,470 - $43,860
1,000 Added 5.7%
18,540 $767,000
Q2 2018

Aug 22, 2018

SELL
$32.98 - $35.16 $4,881 - $5,203
-148 Reduced 0.84%
17,540 $636 Million
Q1 2018

May 10, 2018

BUY
$31.91 - $37.02 $564,424 - $654,809
17,688 New
17,688 $628 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $156B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Elmwood Wealth Management, Inc. Portfolio

Follow Elmwood Wealth Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Elmwood Wealth Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Elmwood Wealth Management, Inc. with notifications on news.